Advisory
Board
Robert
R. Goodwin, Ph.D.
Rob Goodwin is the
President & Chief Operating Office of Ligocyte
Pharmaceuticals Inc., a Bozeman based company focused on
developing new therapies to treat inflammatory disease. Dr.
Goodwin has degrees in Bioengineering from UCLA and the
University of Utah, and has extensive experience in
intellectual property licensing. Formerly the director of
technology transfer at the University of Rochester, he
has also held business development and research positions
in the medical device industry.
Darrel
L. Holmes
Darrel Holmes is the
Director of Operations at Bacterin Inc. in Bozeman,
Montana. He previously worked as the Director of Technical
Operations at Hycor Biomedical and then as a senior manager
at Stratagene Cloning Systems. After moving to Montana, he
became Vice President of Operations and Chief Operating
Officer of Big Spring Water Company. Mr. Holmes has over 25
years of experience in manufacturing activities, material
management, lab testing, engineering and lab safety. He has
expertise in ERP implementation, technology transfer,
product design and manufacturing, as well as extensive
experience in establishing quality control systems and
maintaining medical device and diagnostic operations in
compliance with FDA Quality Systems Requirements and ISO
regulations. Mr. Holmes holds a bachelors degree from
California State University Long Beach.
Thomas
E. Hughes, Ph.D.
Thom Hughes has been
developing ground-breaking fluorescent technologies to
study protein behavior in living cells for over a decade.
Dr. Hughes moved his laboratory to Montana State University
in 2003 from Yale University. He holds degrees from Tufts
and Duke Universities, and has done basic research at
UC San Diego, The Salk Institute, and the Max Planck
Institute for Brain Research in Frankfurt, Germany.
He heads the department of Cell Biology and Neuroscience at
Montana State University and teaches advanced techniques in
molecular neurobiology at Montana State University and The
Cold Spring Harbor Laboratories.
Sharon
Muldoon, Ph.D.
Sharon Muldoon is the
President of Muldoon Scientific Assessment Inc. an
independent consulting company serving the pharmaceutical,
diagnostic and academic communities. Dr. Muldoon holds a
Ph.D. in biochemistry from Stanford University and a B.A.
in biochemistry from UC Berkeley. Dr. Muldoon spent 14
years at Abbott Labs where she held management positions in
product and business development, licensing, marketing and
research and development.
Don Lo, PhD